Press releases
and news

July 29, 2022
Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM
This latest agreement provides Hikma with exclusive rights to commercialise YuflymaTM in all of its MENA markets, strengthening its strategic partnership with Celltrion. To date, Hikma […]
May 26, 2020
Amlak Announces 2019 Full-Year Financial Results
Amlak Finance PJSC, a leading specialised Islamic real estate financier in the Middle East, today announced its full-year financial results for the year ended December 31, […]
May 25, 2020
Hikma were added to the Emertat’s portfolio
Hikma Pharmaceuticals is a multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded in Amman, Jordan […]